the past 20 years, advances in cancer treatment have significantly improved survival rates for young children and older adults, but no significant improvement has been seen in the treatment of adolescent and young adult (AYA) patients with cancer
Search Results
Peter F. Coccia, Jessica Altman, Smita Bhatia, Scott C. Borinstein, Joseph Flynn, Suzanne George, Robert Goldsby, Robert Hayashi, Mary S. Huang, Rebecca H. Johnson, Lynda Kwon Beaupin, Michael P. Link, Kevin C. Oeffinger, Kathleen M. Orr, Alberto S. Pappo, Damon Reed, Holly L. Spraker, Deborah A. Thomas, Margaret von Mehren, Daniel S. Wechsler, Kimberly F. Whelan, Bradley J. Zebrack, Hema Sundar, and Dorothy A. Shead
Peter F. Coccia, Alberto S. Pappo, Lynda Beaupin, Virginia F. Borges, Scott C. Borinstein, Rashmi Chugh, Shira Dinner, Jeanelle Folbrecht, A. Lindsay Frazier, Robert Goldsby, Alexandra Gubin, Robert Hayashi, Mary S. Huang, Michael P. Link, John A. Livingston, Yousif Matloub, Frederick Millard, Kevin C. Oeffinger, Diane Puccetti, Damon Reed, Steven Robinson, Abby R. Rosenberg, Tara Sanft, Holly L. Spraker-Perlman, Margaret von Mehren, Daniel S. Wechsler, Kimberly F. Whelan, Nicholas Yeager, Lisa A. Gurski, and Dorothy A. Shead
the past 20 years, advances in cancer treatment have significantly improved survival rates for young children and older adults, but these improvements have generally not applied to adolescent and young adult (AYA) patients. 1 , 2 One of the main
Jennifer M. Snaman, Deborah Feifer, Gabrielle Helton, Yuchiao Chang, Areej El-Jawahri, Angelo E. Volandes, and Joanne Wolfe
Background Adolescent and young adult (AYA) patients with cancer, defined by the National Cancer Institute as those aged 15 to 39 years, 1 often receive intensive end-of-life (EoL) medical care. 2 – 4 Inadequate knowledge and poor or absent
Katherine Daunov, Michael Daunov, Kara Noskoff, Hilary Gan, Simon Davies, Megan Farrell, Whitney Hadley, Amelia Baffa, Jennifer Giesel, Rachel Egler, Alex Y. Huang, John J. Letterio, and Richard T. Lee
Background Approximately 90,000 adolescents and young adults (AYAs) aged 15 to 39 years are diagnosed with cancer annually. 1 The incidence of cancer in this population is increasing; however, this population has historically not witnessed
Peter F. Coccia, Alberto S. Pappo, Jessica Altman, Smita Bhatia, Scott C. Borinstein, Joseph Flynn, A. Lindsay Frazier, Suzanne George, Robert Goldsby, Robert Hayashi, Mary S. Huang, Rebecca H. Johnson, Lynda Kwon Beaupin, Michael P. Link, Kevin C. Oeffinger, Kathleen M. Orr, Damon Reed, Holly L. Spraker, Deborah A. Thomas, Margaret von Mehren, Daniel S. Wechsler, Kimberly F. Whelan, Brad Zebrack, Dorothy A. Shead, and Hema Sundar
to: Integrate into professional practice the updates to NCCN Guidelines for Adolescent and Young Adult Oncology Describe the rationale behind the decision-making process for developing the NCCN Guidelines for Adolescent and Young Adult Oncology
Julie A. Wolfson, Kelly M. Kenzik, Blake Foxworthy, John M. Salsman, Katherine Donahue, Marie Nelson, Mary Beth Littrell, Grant R. Williams, and Jennifer M. Levine
Adolescents and young adults (AYAs; ages 15–39 years) face unique vulnerabilities when diagnosed with cancer. For several decades, AYAs with cancer have not seen the same improvements in survival as younger (≤14 years) and older (≥40 years
Archie Bleyer
Background In this past spring of 2012, 2 new sets of NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) were published directed at the adolescent and young adult (AYA) population with cancer: those for Adolescent and Young Adult
Damon Reed, Rebecca G. Block, and Rebecca Johnson
screening, increasingly effective therapies, and optimization of supportive care strategies. 3 , 4 Cancer is the most common cause of disease-related death in adolescents and young adults (AYAs) aged 15 to 39 years, 5 although this age group is the least
Michael Koehler, Susanne Hoppe, Siegfried Kropf, Anke Lux, Rainer Bartsch, Bernhard Holzner, Juergen Krauter, Axel Florschütz, Kathleen Jentsch-Ullrich, Joerg Frommer, Hans-Henning Flechtner, and Thomas Fischer
Background Cancer in adolescents and young adults (AYAs; ages 15–40 years) leaves unique health and social disruptions in patients and their families for many years of survivorship even after completing successful cancer therapy. 1 – 4 As
Howland E. Crosswell, Kaitlin N. Bomar, Nicole Vickery, Kristina Stoeppler-Biege, Terra D. Spann, and Robert D. Siegel
Adolescent and young adult (AYA) oncology patients are increasingly recognized in the United States as a vulnerable population, and new models of care delivery have been proposed to improve outcomes and quality of life. 1 , 2 Because
